Anavex Life Sciences CorpNASDAQ:AVXL
- LAST PRICE7.4450
- TODAY'S CHANGE (%)-0.5850 (-7.2852%)
- Bid / Lots7.4200/ 1
- Ask / Lots7.7900/ 2
- Open / Previous Close8.0000 / 8.0300
- Day Range
- 52 Week Range
- Volume2,010,863
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AVXL |
|---|---|---|
| 09:32 ET | 35134 | 8.0566 |
| 09:33 ET | 41083 | 7.91 |
| 09:35 ET | 12577 | 7.94 |
| 09:37 ET | 9312 | 7.995 |
| 09:39 ET | 14741 | 7.92 |
| 09:42 ET | 21924 | 7.865 |
| 09:44 ET | 26825 | 7.9218 |
| 09:46 ET | 5300 | 7.95 |
| 09:48 ET | 19882 | 7.905 |
| 09:50 ET | 28441 | 7.84 |
| 09:51 ET | 8734 | 7.87 |
| 09:53 ET | 18438 | 7.98 |
| 09:55 ET | 3004 | 7.97 |
| 09:57 ET | 3123 | 7.9995 |
| 10:00 ET | 3053 | 7.96 |
| 10:02 ET | 3472 | 7.925 |
| 10:04 ET | 4122 | 7.94 |
| 10:06 ET | 2488 | 7.95 |
| 10:08 ET | 4250 | 7.97 |
| 10:09 ET | 5729 | 7.95 |
| 10:11 ET | 510 | 7.9653 |
| 10:13 ET | 13611 | 7.9786 |
| 10:15 ET | 6884 | 8 |
| 10:18 ET | 15252 | 8.005 |
| 10:20 ET | 4488 | 7.98 |
| 10:22 ET | 3600 | 7.955 |
| 10:24 ET | 5433 | 7.95 |
| 10:26 ET | 3272 | 7.97 |
| 10:27 ET | 2888 | 7.98 |
| 10:29 ET | 17462 | 7.96 |
| 10:31 ET | 9683 | 7.9601 |
| 10:33 ET | 6363 | 7.99 |
| 10:36 ET | 4682 | 7.905 |
| 10:38 ET | 4012 | 7.892581 |
| 10:40 ET | 4600 | 7.91 |
| 10:42 ET | 4577 | 7.915 |
| 10:44 ET | 11669 | 7.845 |
| 10:45 ET | 5281 | 7.815 |
| 10:47 ET | 7236 | 7.84 |
| 10:49 ET | 1710 | 7.865 |
| 10:51 ET | 5040 | 7.87 |
| 10:54 ET | 13556 | 7.8201 |
| 10:56 ET | 5120 | 7.825 |
| 10:58 ET | 3189 | 7.815 |
| 11:00 ET | 7115 | 7.815 |
| 11:02 ET | 20185 | 7.79 |
| 11:03 ET | 18449 | 7.795 |
| 11:05 ET | 6358 | 7.79 |
| 11:07 ET | 6300 | 7.785 |
| 11:09 ET | 14949 | 7.81 |
| 11:12 ET | 6063 | 7.765 |
| 11:14 ET | 10844 | 7.78 |
| 11:16 ET | 18450 | 7.81 |
| 11:18 ET | 5241 | 7.83 |
| 11:20 ET | 7454 | 7.84 |
| 11:21 ET | 3951 | 7.85 |
| 11:23 ET | 7136 | 7.875 |
| 11:25 ET | 3274 | 7.86 |
| 11:27 ET | 11267 | 7.855 |
| 11:30 ET | 9730 | 7.835 |
| 11:32 ET | 28086 | 7.88 |
| 11:34 ET | 5441 | 7.865 |
| 11:36 ET | 6807 | 7.84 |
| 11:38 ET | 4806 | 7.815 |
| 11:39 ET | 9293 | 7.775 |
| 11:41 ET | 3200 | 7.765 |
| 11:43 ET | 12360 | 7.755 |
| 11:45 ET | 18402 | 7.7501 |
| 11:48 ET | 37750 | 7.725 |
| 11:50 ET | 9058 | 7.7201 |
| 11:52 ET | 2100 | 7.725 |
| 11:54 ET | 8172 | 7.735 |
| 11:56 ET | 9055 | 7.755 |
| 11:57 ET | 4870 | 7.75 |
| 11:59 ET | 3875 | 7.77 |
| 12:01 ET | 2300 | 7.765 |
| 12:03 ET | 2240 | 7.745 |
| 12:06 ET | 1900 | 7.745 |
| 12:08 ET | 2150 | 7.72 |
| 12:10 ET | 3822 | 7.76 |
| 12:12 ET | 1400 | 7.76 |
| 12:14 ET | 250 | 7.75 |
| 12:15 ET | 1300 | 7.75 |
| 12:17 ET | 300 | 7.745 |
| 12:19 ET | 4335 | 7.755 |
| 12:21 ET | 2000 | 7.745 |
| 12:24 ET | 1900 | 7.745 |
| 12:26 ET | 2600 | 7.735 |
| 12:30 ET | 1697 | 7.725 |
| 12:32 ET | 11296 | 7.69 |
| 12:33 ET | 4249 | 7.6508 |
| 12:35 ET | 6225 | 7.66 |
| 12:37 ET | 69130 | 7.635 |
| 12:39 ET | 4261 | 7.65 |
| 12:42 ET | 4728 | 7.6399 |
| 12:44 ET | 4869 | 7.59 |
| 12:46 ET | 12857 | 7.585 |
| 12:48 ET | 11374 | 7.5801 |
| 12:50 ET | 5584 | 7.58 |
| 12:51 ET | 3400 | 7.575 |
| 12:53 ET | 4418 | 7.55 |
| 12:55 ET | 1300 | 7.535 |
| 12:57 ET | 5462 | 7.515 |
| 01:00 ET | 17643 | 7.5201 |
| 01:02 ET | 10228 | 7.555 |
| 01:04 ET | 9764 | 7.57 |
| 01:06 ET | 8324 | 7.5849 |
| 01:08 ET | 5462 | 7.62 |
| 01:09 ET | 2953 | 7.6124 |
| 01:11 ET | 150 | 7.62 |
| 01:13 ET | 811 | 7.62 |
| 01:15 ET | 1515 | 7.6184 |
| 01:18 ET | 7412 | 7.5801 |
| 01:20 ET | 5680 | 7.535 |
| 01:22 ET | 1400 | 7.54 |
| 01:24 ET | 7093 | 7.535 |
| 01:26 ET | 7306 | 7.515 |
| 01:27 ET | 9259 | 7.525 |
| 01:29 ET | 1931 | 7.53 |
| 01:31 ET | 200 | 7.53 |
| 01:33 ET | 1647 | 7.53 |
| 01:36 ET | 1627 | 7.515 |
| 01:38 ET | 630 | 7.515 |
| 01:40 ET | 5500 | 7.515 |
| 01:42 ET | 5579 | 7.5073 |
| 01:44 ET | 3168 | 7.51 |
| 01:45 ET | 4971 | 7.51 |
| 01:47 ET | 3702 | 7.51 |
| 01:49 ET | 2673 | 7.505 |
| 01:51 ET | 5916 | 7.54 |
| 01:54 ET | 14697 | 7.535 |
| 01:56 ET | 1590 | 7.52 |
| 01:58 ET | 3272 | 7.525 |
| 02:00 ET | 400 | 7.525 |
| 02:02 ET | 922 | 7.525 |
| 02:03 ET | 1311 | 7.515 |
| 02:05 ET | 4600 | 7.51 |
| 02:07 ET | 3600 | 7.51 |
| 02:09 ET | 5451 | 7.515 |
| 02:12 ET | 1400 | 7.505 |
| 02:14 ET | 3400 | 7.51 |
| 02:16 ET | 500 | 7.505 |
| 02:18 ET | 10140 | 7.505 |
| 02:20 ET | 1495 | 7.5001 |
| 02:21 ET | 32833 | 7.48 |
| 02:23 ET | 11015 | 7.5 |
| 02:25 ET | 5807 | 7.49 |
| 02:27 ET | 5456 | 7.485 |
| 02:30 ET | 1000 | 7.465 |
| 02:32 ET | 2156 | 7.48 |
| 02:34 ET | 1697 | 7.495 |
| 02:36 ET | 2198 | 7.49 |
| 02:38 ET | 885 | 7.47 |
| 02:39 ET | 300 | 7.5 |
| 02:41 ET | 1887 | 7.495 |
| 02:43 ET | 3400 | 7.48 |
| 02:45 ET | 100 | 7.475 |
| 03:14 ET | 300 | 7.435 |
| 03:15 ET | 700 | 7.44 |
| 03:17 ET | 2098 | 7.435 |
| 03:19 ET | 2003 | 7.435 |
| 03:21 ET | 2232 | 7.44 |
| 03:24 ET | 2864 | 7.44 |
| 03:26 ET | 2109 | 7.435 |
| 03:28 ET | 1358 | 7.435 |
| 03:30 ET | 4021 | 7.435 |
| 03:32 ET | 1700 | 7.435 |
| 03:33 ET | 26092 | 7.445 |
| 03:35 ET | 63177 | 7.45 |
| 03:37 ET | 4100 | 7.445 |
| 03:39 ET | 4591 | 7.445 |
| 03:42 ET | 13529 | 7.435 |
| 03:44 ET | 15413 | 7.435 |
| 03:46 ET | 9326 | 7.435 |
| 03:48 ET | 50488 | 7.445 |
| 03:50 ET | 5588 | 7.445 |
| 03:51 ET | 5004 | 7.44 |
| 03:53 ET | 5070 | 7.4415 |
| 03:55 ET | 15838 | 7.445 |
| 03:57 ET | 18335 | 7.445 |
| 04:00 ET | 197842 | 7.445 |
Nov 4, 2024
DJ Anavex Life Sciences Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 6:40AM ET on Monday Nov 04, 2024 by Dow Jones
6:40AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ Anavex Life Sciences Is Maintained at Buy by EF Hutton, from 9:13AM ET on Thursday Oct 31, 2024 by Dow Jones
9:13AM ET on Thursday Oct 31, 2024 by Dow JonesAnavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024, from 4:00AM ET on Thursday Oct 31, 2024 by Dow Jones
4:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 18, 2024
DJ Anavex Life Sciences Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 7:13AM ET on Friday Oct 18, 2024 by Dow Jones
7:13AM ET on Friday Oct 18, 2024 by Dow Jones
Oct 17, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Anavex Life Sciences Corp | 680.9M | -14.9x | --- |
Tourmaline Bio Inc | 689.2M | -15.1x | --- |
Annexon Inc | 668.8M | -5.0x | --- |
BIOAGE Labs Inc | 666.6M | -10.1x | --- |
Oculis Holding AG | 614.1M | -7.1x | --- |
MBX Biosciences Inc | 651.3M | 0.0x | --- |
Company Information
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2 (MECP2). The Company’s product candidates include NAVEX 3-71, ANAVEX 1-41, and ANAVEX 1066. ANAVEX 3-71 is a central nervous system (CNS) penetrable potential disease modifying treatment for cognitive impairments. ANAVEX 1-41 is a sigma-1 agonist.
Contact Information
- Headquarters
- 630 5Th Avenue, 20Th FloorNEW YORK, NY, United States 10111
- Phone
- 800-689-3939
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Company Secretary
- Christopher Missling
- Principal Financial Officer, Treasurer
- Sandra Boenisch
- Independent Director
- Peter Donhauser
- Independent Director
- Jiong Ma
- Independent Director
- Athanasios Skarpelos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $680.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 84.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-0.50 |
Book Value | $1.73 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
